Rivastigmine
Rivastigmine
Rivastigmine (pronounced as ri-vas-TIG-meen) is a type of medication used in the treatment of Alzheimer's disease and Parkinson's disease. It belongs to a class of drugs known as cholinesterase inhibitors.
Etymology
The term "Rivastigmine" is derived from its chemical name, (S)-N-Ethyl-N-methyl-3-[(1-dimethylamino)ethyl]-phenyl carbamate. The name is a combination of parts of its chemical structure, with "Riva" possibly referring to its manufacturer, Novartis, under its former name, Sandoz, and its brand name, Exelon.
Usage
Rivastigmine is used to treat confusion or dementia related to Alzheimer's and Parkinson's disease. It does not cure these diseases, but may improve memory, awareness, and the ability to perform daily functions. This medication works by restoring the balance of certain natural substances (neurotransmitters) in the brain.
Dosage and Administration
Rivastigmine is available in capsule form, oral solution, and transdermal patch. The dosage is based on the patient's medical condition and response to treatment. It is usually started at a low dose to decrease the risk of side effects and gradually increased.
Side Effects
Common side effects of Rivastigmine include nausea, vomiting, loss of appetite, and weakness. If these effects persist or worsen, the patient should contact their doctor or pharmacist promptly.
Related Terms
External links
- Medical encyclopedia article on Rivastigmine
- Wikipedia's article - Rivastigmine
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski